Integrated (Managed) Care Pathway for Stroke Rehabilitation


Phase N/A Results

Trial Description

To evaluate the effectiveness of Integrated Care Pathway (ICP-based) management in reducing the length of hospital stay without affecting functional outcome in stroke patients undergoing specialist rehabilitation.


Trial Design

Prospective, open, randomized trial of 152 patients.

Patient Involvement

Patients were randomized to receive ICP management or conventional care before transfer to the stroke rehabilitation unit when they were medically and neurologically stable. ICP care was organized, goal-defined, and time-managed whereas conventional care was multi-disciplinary and individualized.


Type Measure Time Frame Safety Issue
Primary Hospital length of stay.
Secondary Barthel Activities of Daily Living Index at 1, 4, 12 and 26 weeks; Hospital Anxiety and Depression scale at 4, 12, and 26 weeks; Rankin score and EuroQol Quality of Life Score at 12 and 26 weeks; total therapy time for physiotherapy and occupational therapy measured daily; mortality, cause of death, discharge destination at 26 weeks.


NHS R&D Executive North Thames Research Implementation Committee (Project No. B6.58), NHS Health Technology Assessment grant.